Global and Japan Anti-Malarial Drug Market Insights, Forecast to 2026

    • ID: AR2972412
    • 06 October, 2020
    • Other
    • Region: Global
    • 129 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Anti-Malarial Drug Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Anti-Malarial Drug Manufacturers Covered: Ranking by Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Anti-Malarial Drug Market Size Growth Rate by Type
      • 1.4.2 Plasmodium Falciparum
      • 1.4.3 Plasmodium Vivax
      • 1.4.4 Plasmodium Malariae
      • 1.4.5 Plasmodium Ovale
    • 1.5 Market by Application
      • 1.5.1 Global Anti-Malarial Drug Market Size Growth Rate by Application
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Retail Pharmacy
      • 1.5.4 E-Commerce
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Anti-Malarial Drug Market Size, Estimates and Forecasts
      • 2.1.1 Global Anti-Malarial Drug Revenue 2015-2026
      • 2.1.2 Global Anti-Malarial Drug Sales 2015-2026
    • 2.2 Global Anti-Malarial Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.3 Anti-Malarial Drug Historical Market Size by Region (2015-2020)
      • 2.3.1 Global Anti-Malarial Drug Retrospective Market Scenario in Sales by Region: 2015-2020
      • 2.3.2 Global Anti-Malarial Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 2.4 Anti-Malarial Drug Market Estimates and Projections by Region (2021-2026)
      • 2.4.1 Global Anti-Malarial Drug Sales Forecast by Region (2021-2026)
      • 2.4.2 Global Anti-Malarial Drug Revenue Forecast by Region (2021-2026)

    3 Global Anti-Malarial Drug Competitor Landscape by Players

    • 3.1 Global Top Anti-Malarial Drug Sales by Manufacturers
      • 3.1.1 Global Anti-Malarial Drug Sales by Manufacturers (2015-2020)
      • 3.1.2 Global Anti-Malarial Drug Sales Market Share by Manufacturers (2015-2020)
    • 3.2 Global Anti-Malarial Drug Manufacturers by Revenue
      • 3.2.1 Global Anti-Malarial Drug Revenue by Manufacturers (2015-2020)
      • 3.2.2 Global Anti-Malarial Drug Revenue Share by Manufacturers (2015-2020)
      • 3.2.3 Global Anti-Malarial Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
      • 3.2.4 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Revenue in 2019
      • 3.2.5 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Global Anti-Malarial Drug Price by Manufacturers
    • 3.4 Global Anti-Malarial Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Anti-Malarial Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Anti-Malarial Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Anti-Malarial Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Anti-Malarial Drug Market Size by Type (2015-2020)
      • 4.1.1 Global Anti-Malarial Drug Sales by Type (2015-2020)
      • 4.1.2 Global Anti-Malarial Drug Revenue by Type (2015-2020)
      • 4.1.3 Anti-Malarial Drug Average Selling Price (ASP) by Type (2015-2026)
    • 4.2 Global Anti-Malarial Drug Market Size Forecast by Type (2021-2026)
      • 4.2.1 Global Anti-Malarial Drug Sales Forecast by Type (2021-2026)
      • 4.2.2 Global Anti-Malarial Drug Revenue Forecast by Type (2021-2026)
      • 4.2.3 Anti-Malarial Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
    • 4.3 Global Anti-Malarial Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Market Size by Application (2015-2026)

    • 5.1 Global Anti-Malarial Drug Market Size by Application (2015-2020)
      • 5.1.1 Global Anti-Malarial Drug Sales by Application (2015-2020)
      • 5.1.2 Global Anti-Malarial Drug Revenue by Application (2015-2020)
      • 5.1.3 Anti-Malarial Drug Price by Application (2015-2020)
    • 5.2 Anti-Malarial Drug Market Size Forecast by Application (2021-2026)
      • 5.2.1 Global Anti-Malarial Drug Sales Forecast by Application (2021-2026)
      • 5.2.2 Global Anti-Malarial Drug Revenue Forecast by Application (2021-2026)
      • 5.2.3 Global Anti-Malarial Drug Price Forecast by Application (2021-2026)

    6 Japan by Players, Type and Application

    • 6.1 Japan Anti-Malarial Drug Market Size YoY Growth 2015-2026
      • 6.1.1 Japan Anti-Malarial Drug Sales YoY Growth 2015-2026
      • 6.1.2 Japan Anti-Malarial Drug Revenue YoY Growth 2015-2026
      • 6.1.3 Japan Anti-Malarial Drug Market Share in Global Market 2015-2026
    • 6.2 Japan Anti-Malarial Drug Market Size by Players (International and Local Players)
      • 6.2.1 Japan Top Anti-Malarial Drug Players by Sales (2015-2020)
      • 6.2.2 Japan Top Anti-Malarial Drug Players by Revenue (2015-2020)
    • 6.3 Japan Anti-Malarial Drug Historic Market Review by Type (2015-2020)
      • 6.3.1 Japan Anti-Malarial Drug Sales Market Share by Type (2015-2020)
      • 6.3.2 Japan Anti-Malarial Drug Revenue Market Share by Type (2015-2020)
      • 6.3.3 Japan Anti-Malarial Drug Price by Type (2015-2020)
    • 6.4 Japan Anti-Malarial Drug Market Estimates and Forecasts by Type (2021-2026)
      • 6.4.1 Japan Anti-Malarial Drug Sales Forecast by Type (2021-2026)
      • 6.4.2 Japan Anti-Malarial Drug Revenue Forecast by Type (2021-2026)
      • 6.4.3 Japan Anti-Malarial Drug Price Forecast by Type (2021-2026)
    • 6.5 Japan Anti-Malarial Drug Historic Market Review by Application (2015-2020)
      • 6.5.1 Japan Anti-Malarial Drug Sales Market Share by Application (2015-2020)
      • 6.5.2 Japan Anti-Malarial Drug Revenue Market Share by Application (2015-2020)
      • 6.5.3 Japan Anti-Malarial Drug Price by Application (2015-2020)
    • 6.6 Japan Anti-Malarial Drug Market Estimates and Forecasts by Application (2021-2026)
      • 6.6.1 Japan Anti-Malarial Drug Sales Forecast by Application (2021-2026)
      • 6.6.2 Japan Anti-Malarial Drug Revenue Forecast by Application (2021-2026)
      • 6.6.3 Japan Anti-Malarial Drug Price Forecast by Application (2021-2026)

    7 North America

    • 7.1 North America Anti-Malarial Drug Market Size YoY Growth 2015-2026
    • 7.2 North America Anti-Malarial Drug Market Facts & Figures by Country
      • 7.2.1 North America Anti-Malarial Drug Sales by Country (2015-2020)
      • 7.2.2 North America Anti-Malarial Drug Revenue by Country (2015-2020)
      • 7.2.3 U.S.
      • 7.2.4 Canada

    8 Europe

    • 8.1 Europe Anti-Malarial Drug Market Size YoY Growth 2015-2026
    • 8.2 Europe Anti-Malarial Drug Market Facts & Figures by Country
      • 8.2.1 Europe Anti-Malarial Drug Sales by Country
      • 8.2.2 Europe Anti-Malarial Drug Revenue by Country
      • 8.2.3 Germany
      • 8.2.4 France
      • 8.2.5 U.K.
      • 8.2.6 Italy
      • 8.2.7 Russia

    9 Asia Pacific

    • 9.1 Asia Pacific Anti-Malarial Drug Market Size YoY Growth 2015-2026
    • 9.2 Asia Pacific Anti-Malarial Drug Market Facts & Figures by Country
      • 9.2.1 Asia Pacific Anti-Malarial Drug Sales by Region (2015-2020)
      • 9.2.2 Asia Pacific Anti-Malarial Drug Revenue by Region
      • 9.2.3 China
      • 9.2.4 Japan
      • 9.2.5 South Korea
      • 9.2.6 India
      • 9.2.7 Australia
      • 9.2.8 Taiwan
      • 9.2.9 Indonesia
      • 9.2.10 Thailand
      • 9.2.11 Malaysia
      • 9.2.12 Philippines
      • 9.2.13 Vietnam

    10 Latin America

    • 10.1 Latin America Anti-Malarial Drug Market Size YoY Growth 2015-2026
    • 10.2 Latin America Anti-Malarial Drug Market Facts & Figures by Country
      • 10.2.1 Latin America Anti-Malarial Drug Sales by Country
      • 10.2.2 Latin America Anti-Malarial Drug Revenue by Country
      • 10.2.3 Mexico
      • 10.2.4 Brazil
      • 10.2.5 Argentina

    11 Middle East and Africa

    • 11.1 Middle East and Africa Anti-Malarial Drug Market Size YoY Growth 2015-2026
    • 11.2 Middle East and Africa Anti-Malarial Drug Market Facts & Figures by Country
      • 11.2.1 Middle East and Africa Anti-Malarial Drug Sales by Country
      • 11.2.2 Middle East and Africa Anti-Malarial Drug Revenue by Country
      • 11.2.3 Turkey
      • 11.2.4 Saudi Arabia
      • 11.2.5 U.A.E

    12 Company Profiles

    • 12.1 GlaxoSmithKline
      • 12.1.1 GlaxoSmithKline Corporation Information
      • 12.1.2 GlaxoSmithKline Description and Business Overview
      • 12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 12.1.4 GlaxoSmithKline Anti-Malarial Drug Products Offered
      • 12.1.5 GlaxoSmithKline Recent Development
    • 12.2 Ranbaxy
      • 12.2.1 Ranbaxy Corporation Information
      • 12.2.2 Ranbaxy Description and Business Overview
      • 12.2.3 Ranbaxy Sales, Revenue and Gross Margin (2015-2020)
      • 12.2.4 Ranbaxy Anti-Malarial Drug Products Offered
      • 12.2.5 Ranbaxy Recent Development
    • 12.3 Zydus Cadila
      • 12.3.1 Zydus Cadila Corporation Information
      • 12.3.2 Zydus Cadila Description and Business Overview
      • 12.3.3 Zydus Cadila Sales, Revenue and Gross Margin (2015-2020)
      • 12.3.4 Zydus Cadila Anti-Malarial Drug Products Offered
      • 12.3.5 Zydus Cadila Recent Development
    • 12.4 Alvizia
      • 12.4.1 Alvizia Corporation Information
      • 12.4.2 Alvizia Description and Business Overview
      • 12.4.3 Alvizia Sales, Revenue and Gross Margin (2015-2020)
      • 12.4.4 Alvizia Anti-Malarial Drug Products Offered
      • 12.4.5 Alvizia Recent Development
    • 12.5 Bayer
      • 12.5.1 Bayer Corporation Information
      • 12.5.2 Bayer Description and Business Overview
      • 12.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
      • 12.5.4 Bayer Anti-Malarial Drug Products Offered
      • 12.5.5 Bayer Recent Development
    • 12.6 Ipca
      • 12.6.1 Ipca Corporation Information
      • 12.6.2 Ipca Description and Business Overview
      • 12.6.3 Ipca Sales, Revenue and Gross Margin (2015-2020)
      • 12.6.4 Ipca Anti-Malarial Drug Products Offered
      • 12.6.5 Ipca Recent Development
    • 12.7 Merck
      • 12.7.1 Merck Corporation Information
      • 12.7.2 Merck Description and Business Overview
      • 12.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
      • 12.7.4 Merck Anti-Malarial Drug Products Offered
      • 12.7.5 Merck Recent Development
    • 12.8 F. Hoffmann-La Roche
      • 12.8.1 F. Hoffmann-La Roche Corporation Information
      • 12.8.2 F. Hoffmann-La Roche Description and Business Overview
      • 12.8.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
      • 12.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Products Offered
      • 12.8.5 F. Hoffmann-La Roche Recent Development
    • 12.9 Novartis
      • 12.9.1 Novartis Corporation Information
      • 12.9.2 Novartis Description and Business Overview
      • 12.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
      • 12.9.4 Novartis Anti-Malarial Drug Products Offered
      • 12.9.5 Novartis Recent Development
    • 12.10 Pfizer
      • 12.10.1 Pfizer Corporation Information
      • 12.10.2 Pfizer Description and Business Overview
      • 12.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
      • 12.10.4 Pfizer Anti-Malarial Drug Products Offered
      • 12.10.5 Pfizer Recent Development
    • 12.11 GlaxoSmithKline
      • 12.11.1 GlaxoSmithKline Corporation Information
      • 12.11.2 GlaxoSmithKline Description and Business Overview
      • 12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 12.11.4 GlaxoSmithKline Anti-Malarial Drug Products Offered
      • 12.11.5 GlaxoSmithKline Recent Development

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Porter’s Five Forces Analysis
    • 13.5 Primary Interviews with Key Anti-Malarial Drug Players (Opinion Leaders)

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Anti-Malarial Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Anti-Malarial Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Malarial Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      Segment by Type, the Anti-Malarial Drug market is segmented into
      Plasmodium Falciparum
      Plasmodium Vivax
      Plasmodium Malariae
      Plasmodium Ovale

      Segment by Application, the Anti-Malarial Drug market is segmented into
      Hospital Pharmacy
      Retail Pharmacy
      E-Commerce
      Others

      Regional and Country-level Analysis
      The Anti-Malarial Drug market is analysed and market size information is provided by regions (countries).
      The key regions covered in the Anti-Malarial Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
      The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

      Competitive Landscape and Anti-Malarial Drug Market Share Analysis
      Anti-Malarial Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Malarial Drug business, the date to enter into the Anti-Malarial Drug market, Anti-Malarial Drug product introduction, recent developments, etc.
      The major vendors covered:
      GlaxoSmithKline
      Ranbaxy
      Zydus Cadila
      Alvizia
      Bayer
      Ipca
      Merck
      F. Hoffmann-La Roche
      Novartis
      Pfizer



      Summary:
      Anti-Malarial Drug Market Research Report is about Anti-Malarial Drug Industry study. Get complete Anti-Malarial Drug market research report published after Market Study, Industrial Analysis with Trends & Statistics. Anti-Malarial Drug Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $3,900.00
      $3,900.00
      $3,900.00
      $3,900.00